Females have the survival advantage in glioblastoma

Neuro Oncol. 2018 Mar 27;20(4):576-577. doi: 10.1093/neuonc/noy002.

Authors

Quinn T Ostrom¹, Joshua B Rubin², Justin D Lathia³, Michael E Berens⁴, Jill S Barnholtz-Sloan¹

Affiliations

¹ Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
² Department of Pediatrics and Department of Neuroscience, Washington University School of Medicine, St Louis, Missouri.
³ Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
⁴ Cancer and Cell Biology Division, The Translational Genomics Research Institute, Phoenix, Arizona.

No abstract available

MeSH terms

Brain Neoplasms / mortality*
Brain Neoplasms / pathology
Brain Neoplasms / therapy
Combined Modality Therapy
Female
Follow-Up Studies
Glioblastoma / mortality*
Glioblastoma / pathology
Glioblastoma / therapy
Humans
Male
Multicenter Studies as Topic
Prognosis
SEER Program
Sex Factors
Survival Rate

Grants and funding

R01 CA174737/CA/NCI NIH HHS/United States